Rosemont Pharmaceuticals

Rosemont Pharmaceuticals manufactures and supplies liquid medicines.

Launch date

Dec 1967

Employees

Market cap

Enterprise valuation

AUD373m (Public information from Mar 2013)

Company register number 00924648

Leeds England (HQ & founding location)

http://rosemontpharma.com

https://www.linkedin.com/company/rosemont-pharmaceuticals-limited/

Revenues, earnings & profits over time

GBP	2016	2017	2018	2019	2020	2021	2022
Revenues	46.3m	46.5m	42.7m	41.8m	56.6m	70.8m	89.3m
% growth	(27 %)	-	(8 %)	(2 %)	35 %	25 %	26 %
EBITDA	24.8m	23.4m	21.3m	18.2m	24.5m	41.9m	38.2m
% EBITDA margin	53 %	50 %	50 %	43 %	43 %	59 %	43 %
Profit	(114m)	17.1m	16.0m	14.0m	20.6m	39.0m	36.4m
% profit margin	(246 %)	37 %	38 %	34 %	36 %	55 %	41 %

Date	Investors	Amount	Round
-	Inflexion	N/A	-
Mar 2013	Perrigo	£183m Valuation: £183m 4.8x EV/LTM Revenues 9.8x EV/LTM EBITDA	Acquisition
Total Funding		-

Tech stackLearn more about the technologies and tools that this company uses.

ACQUISITION by Rosemont Pharmaceuticals Jun 2023

ACQUISITION by Rosemont Pharmaceuticals Jun 2024

Sabal Therapeutics

ACQUISITION by Rosemont Pharmaceuticals Jul 2024

Metacel Pharmaceuticals

ACQUISITION by Rosemont Pharmaceuticals Jul 2024

Palmetto Pharmaceuticals

ACQUISITION by Rosemont Pharmaceuticals Jul 2024

Athena Bioscience

ACQUISITION by Rosemont Pharmaceuticals Jul 2024